S
Shinji Tanaka
Researcher at Tokyo Medical and Dental University
Publications - 404
Citations - 13107
Shinji Tanaka is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: Cancer & Hepatocellular carcinoma. The author has an hindex of 61, co-authored 400 publications receiving 12058 citations. Previous affiliations of Shinji Tanaka include Harvard University & Tosoh.
Papers
More filters
Journal ArticleDOI
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
TL;DR: The results suggest thatmiR-124 and miR-203 are novel tumor-suppressive miRNAs for HCC epigenetically silenced and activating multiple targets during hepatocarcinogenesis.
Journal ArticleDOI
Molecular Targeted Therapies in Hepatocellular Carcinoma
Shinji Tanaka,Shigeki Arii +1 more
TL;DR: Molecular targeted therapy with a focus on angiogenesis, growth signals, and mitotic abnormalities, as well as the promising concepts of "cancer stemness" and "synthetic lethality" for the strategy of targeted therapy are summarized.
Journal ArticleDOI
Bile Leakage After Hepatic Resection
Yo-ichi Yamashita,Takayuki Hamatsu,Tatsuya Rikimaru,Shinji Tanaka,Ken Shirabe,Mitsuo Shimada,Keizo Sugimachi +6 more
TL;DR: Patients with bile leakage from the hepatic hilum and postoperative uncontrollable ascites tend to have a poor prognosis, especially when a high-risk surgical procedure is performed in patients with liver cirrhosis, and more careful surgical procedures and use of an intraoperative biles leakage test are recommended.
Journal ArticleDOI
p27 expression and gastric carcinoma.
Masaki Mori,Koshi Mimori,Takeshi Shiraishi,Shinji Tanaka,Hiroaki Ueo,Keizo Sugimachi,Tsuyoshi Akiyoshi +6 more
Journal ArticleDOI
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
Shinji Tanaka,Masaki Mori,Yoshihiro Sakamoto,Masatoshi Makuuchi,Keizo Sugimachi,Jack R. Wands +5 more
TL;DR: A role for Ang2 in the neovascularization of HCC is suggested, which may contribute to the clinical hypervascular phenotype, as well as tumor formation and progression.